Nervovita Medical Technologies

Nervovita Medical Technologies is a pioneer next-generation medical technology company, focusing on the treatments of ground-breaking electrostimulation and defibrillation technologies. We focus on traumatic brain injuries, epilepsy, autism, neuropatic pain and attrial fibrillation. Nervovita, with its expert team, serves as a healthcare partner on vagus neuromodulation therapies and public access defibrillators. We are the technology provider and the distributor of tVNS Health Gmbh, Aurimod and CardiAngel brands and we are active in Turkey, Balkans and Gulf.

Territory management of ground-breaking neuromodulation medical devices and cardiology products for Turkiye, Azerbaijan and Balkans region. Focusing on patients suffering from anxiety, asthma, atrial fibrillation, autism, cognitive impairment, Crohn’s disease, depression, epilepsy, fibromyalgia, inflammation, Parkinson’s disease, Prader-Willi-syndrome, sleep disorders, stroke and tinnitus. Focusing on the building the future of neurostimulation,and supporting clinical research and treatment protocols.